Regulated Aesthetic & Cosmetic Clinics
Regulatory and governance support for aesthetic and cosmetic clinics where CQC registration, clinical accountability and patient-safety requirements apply.
Establishing whether the service falls within CQC regulation
Aesthetic and cosmetic services may provide CQC-regulated activities, non-regulated cosmetic interventions, or a combination of both. The regulatory position depends on the activity undertaken, its purpose, who provides it and the circumstances in which it is delivered.
Oxara reviews the service model, practitioners, locations and patient pathways to establish which regulated activities may apply, whether the provider's registration reflects the service being delivered, and whether the associated governance arrangements are appropriate.
Regulated and non-regulated activity must be identified correctly
Not every aesthetic or cosmetic intervention is a regulated activity. Botulinum toxin injections, dermal fillers, chemical peels, laser and IPL treatments are not automatically within CQC's scope simply because they are delivered in a clinical setting or by a healthcare professional.
The relevant question is whether the activity falls within one of the regulated activities defined by the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014. This requires consideration of the procedure, its purpose, the professional delivering it and the wider clinical service in which it is provided.
A clinic may operate wholly outside CQC registration, wholly within it, or provide both regulated and non-regulated services. Oxara reviews the actual operating model and the evidence supporting it rather than relying on treatment names or marketing descriptions.
Registration must reflect the service being operated
Where CQC registration is required, relevant regulated activities may include Surgical Procedures and Treatment of Disease, Disorder or Injury. The applicable regulated activity depends on what is provided, why it is provided and who carries it out.
The provider's regulated activities, registered locations and Statement of Purpose must remain consistent with the service being delivered. Changes to treatments, locations, clinical teams or the purpose of an existing service can alter the registration position.
Oxara reviews the current operating model against the provider's registration and identifies where an application, variation or other registration change may be required.
Registration Variations & Changes covers that work in detail.
Need to check whether the clinic’s treatments, practitioners and operating model fall within CQC registration?
Discuss Your Regulatory PositionGovernance must account for the whole clinical model
A clinic may provide regulated and non-regulated treatments from the same premises, using the same practitioners, administrative systems and clinical records. The distinction between the activities must therefore be clear within the service's governance arrangements.
The provider should be able to identify who holds clinical responsibility for each pathway, which standards apply to the records generated, how prescribing and medicines are managed, and how responsibility is transferred where patients move between different elements of the service.
Complications, incidents, complaints or safeguarding concerns arising from one part of the business may have implications for another. Arrangements for recognition, escalation, investigation and learning should therefore be defined across the service rather than left to individual practitioners.
Oxara reviews how regulated and non-regulated pathways interact and whether the provider can demonstrate effective oversight of the activities for which it is accountable.
Patient selection and consent require documented clinical judgement
Before treatment is provided, the clinic should have a clear process for assessing clinical suitability, relevant medical history, contraindications, previous treatment and the patient's expectations of the proposed intervention.
Consent should address the nature and purpose of the intervention, material risks, likely outcomes, available alternatives and appropriate follow-up. Where professional guidance requires a period for reflection, the clinical record should demonstrate that this has been provided.
The assessment should also identify circumstances in which treatment may not be appropriate, including concerns about vulnerability, unrealistic expectations or psychological factors affecting the request for treatment. Any decision not to proceed, or to seek further assessment, should be documented.
Oxara reviews the consent and patient-selection processes against the clinical records and the way the service operates in practice.
Provider oversight must extend to every practitioner delivering the service
Aesthetic and cosmetic clinics may use employed clinicians, self-employed practitioners, visiting specialists, practising-privilege arrangements or other contractual models. The provider's governance arrangements must define how those practitioners are authorised, assessed and monitored.
Defined provider-level and practitioner accountability, verification of professional registration, and evidence that each practitioner works within their competence and agreed scope of practice.
Professional registration, indemnity, references, induction, competence assessment, ongoing review and arrangements for restricting or withdrawing practice where concerns arise.
Consistent arrangements for recording, reviewing, investigating and learning from incidents, adverse outcomes, complications and complaints, including events identified after the patient has left the clinic.
Processes for recognising vulnerability or safeguarding concerns, staff training, referral and escalation, and records demonstrating the action taken.
A defined audit programme covering relevant clinical and governance risks, documented findings, accountable actions and evidence that identified improvements have been completed and sustained.
Mandatory and role-specific training, evidence of competence, and consistent clinical-record standards across employed, contracted and visiting practitioners.
Governance & Compliance Audits provides independent review of these arrangements and the evidence supporting them.
Prescribing and medicines require clear clinical accountability
Where prescription-only medicines are used, the prescriber remains responsible for the prescribing decision and the clinical assessment supporting it. The clinic should be able to demonstrate who assessed the patient, who prescribed the medicine and how the prescribing decision relates to the treatment provided.
Governance should also cover medicine procurement, storage, stock control, administration records, expiry checks, adverse reactions and the emergency medicines required for the treatments undertaken. Prescribing records and treatment records should be capable of being reconciled.
The NMC requires nurse and midwife prescribers to undertake a face-to-face consultation and documented clinical assessment before prescribing medicines for elective non-surgical cosmetic procedures. Remote prescribing does not meet that NMC requirement. Other prescribing professions are subject to the requirements of their own professional regulators.
Oxara reviews the prescribing and medicines pathway against the clinical records, practitioner arrangements and governance controls in operation.
Clinical risks and complications require defined controls
Safe delivery requires appropriate infection-prevention controls, premises, decontamination arrangements, equipment maintenance, single-use systems where applicable, and treatment environments suitable for the procedures undertaken.
The clinic should have documented arrangements for recognising and responding to deterioration or treatment complications. These should address staff competence, emergency medicines and equipment, access to emergency services and transfer to acute care where required.
Discharge criteria, follow-up arrangements and access to clinical advice after treatment should be defined. Complications identified after discharge should be recorded, reviewed and included within the provider's clinical-governance processes.
Where the service undertakes procedural or minor-surgical activity, Procedural & Minor-Surgery Clinics addresses the additional governance requirements associated with that setting.
Governance evidence must correspond with clinical practice
Policies and standard operating procedures describe the provider's intended systems. Clinical and governance records show whether those systems are being used. Direct review of the service establishes whether practice is consistent with both.
Material discrepancies may indicate a governance weakness. Examples include consent arrangements that are described in policy but not evidenced in clinical records, complications that are managed clinically but not entered into the incident system, or audits that identify repeated findings without completed action.
Oxara triangulates written systems, records and operational practice to identify where the evidence supports the provider's stated arrangements and where further action is required.
Mock Inspections & Inspection Readiness assesses this evidence against the service's regulatory requirements and operating practice.
Regulatory and governance support matched to the service
Assessment of the treatments, practitioners, locations and patient pathways to establish which regulated activities may apply and whether CQC registration is required.
Support with registration requirements where a clinic is opening, adding or changing regulated activities, changing locations or altering an existing service model.
Independent review of clinical governance, practitioner oversight, consent, prescribing, medicines, records, incidents, safeguarding and quality-assurance systems.
Evidence review and operational preparation where CQC inspection is approaching or where concerns have been raised about registration, governance or patient safety.
Future regulation of non-surgical cosmetic procedures
Section 180 of the Health and Care Act 2022 gives government the power to introduce a licensing scheme in England for specified non-surgical cosmetic procedures. The detailed scheme requires secondary legislation and should not be presented as an existing licensing requirement.
Providers should continue to comply with the regulatory and professional requirements that currently apply to their services while monitoring further legislation affecting non-surgical cosmetic practice.
Regulatory and governance support for aesthetic and cosmetic clinics
Oxara supports providers with regulatory-scope assessment, registration changes, clinical governance, inspection preparation and regulatory concerns affecting aesthetic and cosmetic services.